AlphaProteo yeast-display binding screen, hit at binding signal above 1.3 (IL-17A)
Share of tested binder designs whose yeast-display flow-cytometry binding signal exceeds 1.3, the threshold used for IL-17A.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
2 recorded evaluations, 2 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
2 evaluations · 2 results. Different protocols are not a single leaderboard.
Protocol: AlphaProteo yeast-display binding screen, hit at binding signal above 1.3 (IL-17A) · Dataset: AlphaProteo binder design target IL-17A
Sorted by Hit rate (yeast-display binding signal above 1.3, over designs tested; pooled over the AlphaProteo design systems tested for this target) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Hit rate (yeast-display binding signal above 1.3, over designs tested; pooled over the AlphaProteo design systems tested for this target) | Hit rate (yeast-display binding signal above 1.3, over designs tested) |
|---|---|---|
| AlphaProteo, pooled over tested design systemsEvaluation | 14% | Not reported |
| AlphaProteo v1Evaluation | Not reported | 14.3% |
All 2 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: AlphaProteo v1 | Protocol: AlphaProteo yeast-display binding screen, hit at binding signal above 1.3 (IL-17A) Dataset: AlphaProteo binder design target IL-17A | 14.3% Hit rate (yeast-display binding signal above 1.3, over designs tested) percent · higher Uncertainty: Not reported by the source: No interval is printed. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceAlphaProteo v1 on IL-17A (yeast-display hit rate, Table S2) uc-binder-20261022-protocol-alphaproteo-yeast-display-signal-1-3 Aggregation: Not reported De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024) · Table S2, 'Success (%)' block, row 'AlphaProteo v1', column 'IL-17A' |
| Configuration: AlphaProteo, pooled over tested design systems | Protocol: AlphaProteo yeast-display binding screen, hit at binding signal above 1.3 (IL-17A) Dataset: AlphaProteo binder design target IL-17A | 14% Hit rate (yeast-display binding signal above 1.3, over designs tested; pooled over the AlphaProteo design systems tested for this target) percent · higher Uncertainty: Not reported by the source: No interval or replicate count is printed. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceAlphaProteo on IL-17A, pooled over tested design systems (yeast-display hit rate, Table 1) uc-binder-20261022-protocol-alphaproteo-yeast-display-signal-1-3 Aggregation: Not reported De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024) · Table 1, 'Experimental success rate (%)' block, row 'AlphaProteo', column 'IL-17A' |
Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 2
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Select a task-valid null control after reviewing inputs and metric
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Select an upstream conventional reference after reviewing the full protocol
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-10-22-1b7cf027e4f6. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
1 source record and release history
- De novo design of high-affinity protein binders with AlphaProteo (Zambaldi et al., arXiv 2024) · Original source · arXiv version 1, posted 2024-09-12; full-text PDF (49 pages)
Technical metadata and extraction receipts
Stable ID: uc-binder-20261022-protocol-alphaproteo-yeast-display-signal-1-3
- areas
- proteins-complexes; protein-structure
- contexts
- research
- comparison limit
- A different hit threshold from the other seven targets, so IL-17A rates are not comparable with them.
- limitations
- Developer-reported: the authors built AlphaProteo, chose the targets, ran the assay and chose which designs to test.; A hit is a flow-cytometry binding signal above a manually calibrated threshold, not an affinity. The thresholds 'were calibrated manually by visually inspecting scatterplots of the raw yeast data' (Section S1.2.1).; The designs tested were chosen by the authors' own automated filter from a larger in silico set, so the design step and the selection step are coupled.; Denominators are small (30 to 172 designs per target) and no uncertainty is printed.; No conventional comparator (directed evolution, display selection or grafting) was run on these targets.; Target concentrations were 0.5 to 1 micromolar, 10- to 20-fold lower than in the RFdiffusion publication, 'which may exclude lower-affinity hits' (Section S4.1).
- metric
- hit-rate
- metric direction
- higher
- metric qualifier
- yeast-display binding signal above 1.3, over designs tested
- protocol
- As the 0.2-threshold screen, but with the binding-signal threshold set to 1.3 'to account for background binding' on IL-17A. For VEGF-A and IL-17A an avidity method with increased sensitivity was used, in which target proteins were pre-incubated with FITC antibody and streptavidin-phycoerythrin before incubation with cells.
- review
- artifact sha256: 953b35644c0fa06ff090d7614c2e19525831f8fde50242e176d54474133c5a42; method: source-hash-verification; independent-cell-check; ai-assisted-source-review; method note: Re-downloaded with curl (HTTP 200, 12,333,400 bytes) and the SHA-256 recomputed and matched. Own text layer made with pdftotext -layout (poppler 26.08.0), reproducing the extraction pass's 2,811 lines. Table 1, Table S2, Table S3 and Sections S1.2.1, S2, S4.1 and S4.2 read cell by cell and compared with every record. Column assignment re-derived arithmetically rather than trusted.; note: Reviewed in docs/reviews/use-cases/binder-2026-10-22.md. Automated AI review of the source transcription only; it is not human scientific review and nothing here was reproduced experimentally.; retrieval url: https://arxiv.org/pdf/2409.08022v1; reviewed at: 2026-10-22T15:00:00Z; reviewer: claude; reviewer note: Claude review agent, independent of the extraction agent; no human review claimed
- source locator
- Section S1.2.1; Table 1, column 'IL-17A'
- success threshold
- criterion: yeast-display flow-cytometry binding signal > 1.3; locator: Section S1.2.1; scope: IL-17A only
- unit
- percent
- version
- arXiv:2409.08022v1 Section S1.2.1